Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide
- 1 December 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (18) , 2948-2957
- https://doi.org/10.1016/j.ejca.2005.08.027
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chemopotentiation by PARP inhibitors in cancer therapyPharmacological Research, 2005
- PARP-1 inhibition to treat cancer, ischemia, inflammationPharmacological Research, 2005
- Poly(ADP-ribose) is required for spindle assembly and structureNature, 2004
- The PARP superfamilyBioEssays, 2004
- Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartmentsExperimental Cell Research, 2004
- Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361JNCI Journal of the National Cancer Institute, 2004
- Human poly(ADP-ribose) glycohydrolase (PARG) gene and the common promoter sequence it shares with inner mitochondrial membrane translocase 23 (TIM23)Gene, 2003
- Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cellsBiochemical and Biophysical Research Communications, 2003
- Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system siteBlood, 2002
- Importance of Poly(ADP-Ribose) Glycohydrolase in the Control of Poly(ADP-Ribose) MetabolismExperimental Cell Research, 2001